Does EXEMESTANE Cause Tumour marker increased? 124 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 124 reports of Tumour marker increased have been filed in association with EXEMESTANE (Exemestane). This represents 1.2% of all adverse event reports for EXEMESTANE.
124
Reports of Tumour marker increased with EXEMESTANE
1.2%
of all EXEMESTANE reports
2
Deaths
20
Hospitalizations
How Dangerous Is Tumour marker increased From EXEMESTANE?
Of the 124 reports, 2 (1.6%) resulted in death, 20 (16.1%) required hospitalization, and 2 (1.6%) were considered life-threatening.
Is Tumour marker increased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EXEMESTANE. However, 124 reports have been filed with the FAERS database.
What Other Side Effects Does EXEMESTANE Cause?
Fatigue (1,122)
Malignant neoplasm progression (1,025)
Arthralgia (943)
Diarrhoea (941)
Nausea (913)
Neoplasm progression (692)
Dyspnoea (673)
Malaise (620)
Headache (606)
Asthenia (597)
What Other Drugs Cause Tumour marker increased?
PALBOCICLIB (817)
FULVESTRANT (408)
NIRAPARIB (356)
LETROZOLE (343)
RIBOCICLIB (317)
RUCAPARIB CAMSYLATE (257)
CAPECITABINE (228)
EVEROLIMUS (228)
ELACESTRANT (222)
OLAPARIB (171)
Which EXEMESTANE Alternatives Have Lower Tumour marker increased Risk?
EXEMESTANE vs EXENATIDE
EXEMESTANE vs EXFORGE
EXEMESTANE vs EXJADE
EXEMESTANE vs EXTAVIA
EXEMESTANE vs EXTRANEAL